Moving Up The Value Chain With New Chemistries

Business Highlights H1FY24 Rs.6,772 mn Revenue Rs.604 mn EBITDA Rs.35 mn PAT K R Bodal Chemicals Ltd. COLOURS. INTEGRATION. INNOVATION. DuringH1FY24, Turnover declined due to decline in prices of RM as well as FG. Margin for the Q2FY24 has remain similar but H1FY24 has declined as there was better performance in Q1FY23. Demand for the quarter was once again subdued. Total revenue for the H1FY24 stood at Rs.6,772 mn, a de- growth of 22% on a YoY basis. Inflation in major economies continuous to be higher level than the normal leading to lower purchasing power with mass. Which results in lower consumption at end user industries and lower demand for our industry. Uncertainty for end of war between Russia and Ukraine further decelerated demand scenario of chemical industry. Slow exports for textile, leather and paper leading to subdued performance of Dyestuff over the last few quarters. Revenue contribution from dyestuff stood at Rs 2,266 mn in H1FY24, has reported de-growth of 28% on a YoY basis. On positive side, Dyes intermediates revenue stood at Rs.2,048 mn in H1FY24, has reported growth of 16% on YoY basis mainly on account of improved volume. In Basic chemicals Sulphuric Acid and other products, despite of growth in volume by 12%, the revenue stood at Rs.631 mn, a de growth 42% YoY basis. This decline in revenue is due to decline in prices of RM as well as FG. Average prices of our key products, i.e., H Acid and Vinyl Sulphone in Q2FY24 to Rs 419 per kg and Rs.215 per kg, respectively. Chlor Alkali business has reported de-growth in revenue as well as steep decline in margin due to adverse market condition of Caustic-Chlorine industry. In H1FY24, post up-gradation capex, despite of growth in volume by 16%, due to a substantial price reduction, Chlor Alkali revenue stood at 1,293 mn, a de growth 26% on YoY basis. Sener Boya, our Turkish company, has performed satisfactory though there is global headwinds in chemicals industry. Whereas other subsidiaries have incurred nominal loss. Management is taking measures in terms of scale, costs and integration that will help to sail through in this tough time. Our Saykha Greenfield Project is expected to start trial run of Benzene Derivatives in Q3FY24. Once we have decent visibility of demand for our product portfolio and new site is stabilized, we will restart the Sulphuric Acid project. * On Consolidated basis 4 st R

View entire presentation